This message was sent to ##Email##
Registration for the ASHI Regional Education Workshop 1 in Las Vegas, Nevada from April 12-14, 2018 is now available.
Register by Tuesday, March 13 to take advantage of our early registration rates.
The preliminary program for the ASHI Regional Education Workshops is now available! The 2018 Regional Education Workshops touch on topics ranging from the Basics of Transplant Immunology to the Reasoning Behind HLA Antibody Testing and the Interpretation of MFI in Antibody Testing. The faculty will also speak on NGS HLA Typing for Solid Organ Transplantation to Quality Control for NGS. Click here to view the preliminary program.
Travel awards are available to qualified applicants. Click here to apply.
SAVE THE DATE!
ASHI REGIONAL EDUCATION WORKSHOP 2:
Hilton Garden Inn Cleveland Downtown
1100 Carnegie Ave.
June 28-30, 2018
Check back often for more information about the 2018 ASHI Regional Education Workshops.
HLA pioneer and former ASHI president Paul Terasaki is being inducted to the National Inventors Hall of Fame® (NIHF) or his invention of Tissue Typing for Organ Transplants.
In the 1960s, UCLA professor Paul Terasaki invented a tissue-typing test that became an international standard for matching potential organ donors with recipients. The procedure, used for kidney, heart, liver, pancreas, lung, and bone marrow donors and recipients, remained for decades the most common method of HLA antibody screening. Terasaki also founded the first kidney transplant registry, and his contributions to developing a cold storage solution for kidney preservation during shipping helped define the field of transplantation science.
Click here to learn more about the NIHF's 2018 Class of Inductees.
Once again this year, we are inviting all ASHI members to showcase their artistic talent, their commitment to the society, and to the field of histocompatibility and immunogenetics by participating in a poster contest to celebrate 2018 Medical Laboratory Professionals Week! This poster contest will help to promote and recognize the dedicated efforts of laboratory professionals.
The first place winner will receive the honor of having their artwork showcased in a poster which will be distributed to all ASHI accredited labs for 2018 Medical Laboratory Professionals Week.
Click here for the rules for the poster contest. Please read the poster contest rules carefully, as only posters that meet the contest rules will be considered. In addition, the ASHI website can provide you with information on the science and application of histocompatibility and immunogenetics. You may use all or any part of this information to help you design your poster.
We hope you will participate in this worthwhile activity and look forward to working with you! If you have any questions, please contact ASHI Headquarters at ASHI Headquarters.
Monday, February 5, 2018
Email ASHI Headquarters with your intent to submit a poster. We've already received one submission of intent, so hurry and email us now to join the fun!
Sunday, February 25, 2018 at 11:59 PM Eastern
Email your posters to ASHI Headquarters in order to be considered.
VxMatch now features full LIMS integration, MFI cut-offs and custom visualizations. VxMatch is a dedicated application that displays DSA trends, dilution and reactivity history and has been validated at leading HLA labs. Click here to schedule a full demo or view our recent ASHI poster on VxMatch to learn more.
Dr. Effie Petersdorf and ASHI Member/Board Member, Dr. Rob Liwski, are confirmed speakers at the Asia–Pacific Histocompatibility & Immunogenetics Association (APHIA) conference held on November 11 – 14, 2018 at the Sydney Masonic Center in Sydney.
Click here for additional conference details or visit aphia2018.org.
Name & Credentials: Renato M. Vega, BS, CHS
Job Title: Laboratory Supervisor
Place of employment: Johns Hopkins University
Graduated from: York College of Pennsylvania
How long have you been an ASHI member? 16 years
When did you attend your first ASHI meeting? My first ASHI meeting was in Miami, Florida in 2003.
To be our next ASHI Member Spotlight, click here now! You can also nominate a co-worker or fellow colleague by contacting Mandi Cruz at Mcruz@ashi-hla.org.
The 2017 HT-2 and EMO-2 Summary and Performance Reports are now available in the OLD PT Lab Center. Click here to login to the old PT Lab Center to view your reports. Please use your former login information (email address and corresponding password) to log into the old PT Lab Center.
If your laboratory subscribed to the 2017 AC-2 survey, the Summary and Performance reports are not yet finalized. You will be notified by email once they are available for your review. We appreciate your patience with report release delays as we work to integrate our new ASHI PT software and reporting systems.
2018 PT Ordering Tips and Information
The deadline for placing your 2018 PT order is Feb. 16, so if your lab has not placed a 2018 PT order, please be sure to log into the new PT Lab Center with your Lab's log-in information to place your order.
Click here for information regarding PO's, paper forms, and problems logging-in.
ASHI will sponsor two joint symposia at FOCIS 2018 - one with the American Society of Transplantation and The Transplantation Society and the other with The Association of Medical Laboratory Immunologists. FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. For more information, click here.
Gift of Life Michigan applied and was awarded ASHI funding for a local histocompatibility meeting in December 2017. Transplant centers from Michigan as well as Toledo were present. Dr. Robert Liwski from Dalhousie University in Halifax, Nova Scotia was the invited speaker for the meeting. Click here to read more and see pictures from the meeting.
For more information on how your lab can receive funding to hold a local histocompatibility meeting, click here.
Do you want to learn new skills? Meet new people? Advance in your career? Sign up to be an ASHI Volunteer! Learn more about the many benefits of volunteering by visiting the ASHI WANTS YOU volunteer page on the ASHI website.
We also offer several easy, low-commitment tasks. So, if you are not sure about volunteering, or simply can't make a full commitment, try out one of our micro-volunteering opportunities. Sign up today by clicking here!
Here's the latest question:
What specifics do you think are false positives on the single antigen assays?
It's not too late, click here to join the discussion!
The Travel Fund Award was created to help new ASHI members attend regional and annual meetings. ASHI is able to continue its mission because of your support and generosity. By contributing to the travel fund award, you'll help us give more educational and career building opportunities to our members.
Online donations are quick and easy using our secure credit card transactions. We welcome donations of all sizes. Donate today by clicking here!
In June 2015, the OPTN/UNOS Board of Directors approved a rewrite of the histocompatibility bylaws that included the general supervisor to the list of laboratory key personnel. The implementation of the addition of this new requirement was delayed to allow for the development of a new key personnel application form, which then needed approval by the Office of Management and Budget (OMB). The OMB has recently approved the new general supervisor key personnel application form.
As part of the implementation of this bylaw, UNOS will send the OPTN general supervisor key personnel application to all OPTN approved histocompatibility laboratories. All approved histocompatibility laboratories will be asked to complete and submit the general supervisor key personnel application form within 30 days.
The effective date of the general supervisor key personnel requirement bylaw will coincide with the date that the Membership and Professional Standards Committee acts on all the general supervisor applications received during the 30-day submission period. All OPTN approved histocompatibility laboratories will need to submit this form within the 30-day period to remain in compliance with the histocompatibility laboratory membership requirements. If UNOS receives the application after the deadline, UNOS cannot guarantee that it will be processed prior to the implementation date. The new bylaw language can be found in the Histocompatibility Bylaws Rewrite Phase II policy notice on the OPTN website. UNOS will implement the general supervisor key personnel requirement for histocompatibility laboratories on the following schedule:
February 27, 2018: Effective date of general supervisory key personnel bylaw. Notice will be provided 30 days prior to the effective date.
If you have any questions, please contact Christi Manner, Jasmine Smith or Tierra Simpkins by phone at (804) 782-4800 or by email using the format firstname.lastname@example.org.
Mark your calendar now for future ASHI Annual Meetings!
Have you renewed your ASHI membership for 2018? If not, do it now to avoid a disruption of your ASHI benefits!
ASHI Memberships expired on December 31, 2017. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Click here to renew today!
If you are experiencing trouble with your ASHI website username or password, contact Membership Coordinator, Mandi Cruz at email@example.com.
The risk of acute graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation is increased with donor-recipient HLA-DPB1 allele mismatching. The single-nucleotide polymorphism (SNP) rs9277534 within the 3' untranslated region (UTR) correlates with HLA-DPB1 allotype expression and serves as a marker for permissive HLA-DPB1 mismatches.
Sarcoidosis is a granulomatous disease of unknown etiology. Macrophages play a key role in granuloma formation with the T cells, having a significant impact on macrophage polarization (M1 and M2) and the cellular composition of the granuloma. This study evaluates macrophage polarization in granulomas in pulmonary sarcoidosis.
NLRP3 inflammasome has been recently reported as an important risk factor in the development of cancer. But the relationship between polymorphisms of NLRP3 inflammasome related genes and chronic myeloid leukemia (CML) is rarely reported.
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8